Main
>
ONCOLOGY (**)
>
Thyroid Cancer>Anaplastic>MET>***
>
TREAT.:
>
Co: CH. N. Dabrafenib+Trametinib
>
(*) USA Approval Date: 2018. 05.04.
(*) USA Approval Date: 2018. 05.04.'s products
This section has no products